PON1 and oxidative stress in human sepsis and an animal model of sepsis

Advances in Experimental Medicine and Biology

Volumn 660, Issue , 2010, Pages 89-97

  Draganov, Dragomir ^a   Teiber, John ^a   Watson, Catherine ^a   Bisgaier, Charles ^a   Nemzek, Jean ^a   Remick, Daniel ^a   Standiford, Theodore ^a   Du, Bert La ^a  

^a NONE

Author keywords

Cecal ligation and puncture model; Critically ill patients; High density lipoprotein; Lipid peroxides; Oxidative stress; Sepsis; Systemic inflammatory response; Thiobarbituric acid reacting substances; Total antioxidant activity

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID PEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE COURSE; DISEASE MODEL; ENZYME ACTIVITY; FATALITY; FEMALE; HUMAN; INTENSIVE CARE UNIT; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALS; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; LIPID PEROXIDES; LIPOPROTEINS, HDL; MICE; MICE, INBRED BALB C; OXIDATIVE STRESS; SEPSIS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TIME FACTORS;

ANIMALIA; MURINAE;

EID: 79952754303     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60761-350-3_9     Document Type: Article

References (19)

1. Abraham E, Singer M (2007) Mechanisms of sepsis-induced organ dysfunction. Crit Care Med 35:2408-2416 (Pubitemid 47476242)
2. Aviram M, Rosenblat M. (2004) Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic Biol Med 37:1304-1316 (Pubitemid 39349234)
3. Aviram M, Rosenblat M. (2005) Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences. Curr Opin Lipidol 16:393-399 (Pubitemid 41017622)
4. Berger M, Chiolero RL (2007) Antioxidant supplementation in sepsis and systemic inflammatory response syndrome. Crit Care Med 35(Suppl):584-590
5. Chien J-Y, Jerng J-S, Yu C-J et al. (2005) Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med 33:1688-1693 (Pubitemid 41153691)
6. Costa LG, Vitalone A, Cole TB et al. (2005) Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 69:541-550
7. De Backer D (2007) Benefit-risk assessment of drotrecogin alfa (activated) in the treatment of sepsis. Drug Saf 30:995-1010 (Pubitemid 350036601)
8. Draganov DI, Teiber JF, Billecke SS et al. (2008) Serum paraoxonase (PON1) and apolipoprotein A-I (apoA-I) are reduced in critically ill patients with sepsis. Manuscript in preparation.
9. Goode HF, Cowley HC, Walker BE et al. (1995) Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med 23:646-651
10. Gordon BR, Parker TS, Levine DM et al. (1996) Low lipid concentrations in critically illness: implications for preventing and treating endotoximia. Crit Care Med 24:584-589 (Pubitemid 26133790)
11. Gordon BR, Parker TS, Levine DM et al. (2001) Relationship of hypolipidemia in cytokine concentrations and outcome in critically ill surgical patients. Crit Care Med 29:1563-1568 (Pubitemid 32762337)
12. Martin GS, Mannino DM, Eaton S et al. (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546-1554 (Pubitemid 36437931)
13. James RW, Deakin SP (2004) The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity. Free Radic Biol Med 15:1986-1994 (Pubitemid 39491318)
14. Navab M, Yu R, Gharavi N, Huang W et al. (2007) High-density lipoprotein: antioxidant and anti-inflammatory properties. Curr Atheroscler Rep 9:244-248 (Pubitemid 47629072)
15. Ng CJ, Shih DM, Hama SY et al. (2005) The paraoxonase gene family and atherosclerosis. Free Radic Biol Med 38:153-163 (Pubitemid 39656127)
16. Remick DG, Newcomb DE, Bolgos GL et al. (2000) Comparison of themortality and inflammatory response of two models of sepsis: lipopolysacharide vs. cecal ligation and puncture. Shock 13:110-116
17. Remick DG, Bolgos GR, Siddiqui J et al. (2002) Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days. Shock 17:463-467
18. Van Leeuwen HJ, Heezius EC, Dallinga GM et al. (2003) Lipoprotein metabolism in patients with severe sepsis. Crit Care Med 31:1359-1366 (Pubitemid 36583844)
19. Wu A, Hinds CJ, Thiemermann C (2004) High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications. Shock 21:210-221